![Open access](/images/ico/o.png)
![](/images/ico/ico5.png)
Author: Alraddadi Eman A. Lillico Ryan Vennerstrom Jonathan L. Lakowski Ted M. Miller Donald W.
Publisher: MDPI
E-ISSN: 1999-4923|10|1|31-31
ISSN: 1999-4923
Source: Pharmaceutics, Vol.10, Iss.1, 2018-03, pp. : 31-31
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/o.png)
![](/images/ico/ico5.png)
![](/images/ico/o.png)
![](/images/ico/ico5.png)
![](/images/ico/o.png)
![](/images/ico/ico5.png)
Strategies to Overcome Heparins’ Low Oral Bioavailability
By Neves Ana Rita Correia-da-Silva Marta Sousa Emília Pinto Madalena
Pharmaceuticals, Vol. 9, Iss. 3, 2016-06 ,pp. :
![](/images/ico/o.png)
![](/images/ico/ico5.png)